15 articles in this category
We imagine a future where aging is optional. Pills, gene edits, organ printers — the tech gets the headlines. But nobody talks about the paperwork. Wh...
Your phone's battery is glued shut. Your laptop's RAM is soldered. Your car's headlight is sealed—replace the whole assembly or nothing. We've been to...
Materials fatigue is predictable. Steel stress curves, polymer half-lives, concrete creep—engineers model them with precision. But ethical decay? That...
So you've built a dashboard. Epigenetic clocks ticking down, DNAm age dropping, maybe a GrimAge score that looks great. But something gnaws at you. Th...
Let's say you're designing a solar panel that should last 40 years. You pick a frame made from a new aluminum alloy — strong, light, recyclable. Great...
You design a laptop that lasts 15 years. The battery is replaceable, the RAM is socketed. You feel good about the planet. But then the customer suppor...
In 2022, a well-funded longevity startup paused its first human trial. Not because of safety data — safety looked fine. Because an internal memo, leak...
Sometime in the next decade, a drug cocktail could add ten years to human median lifespan. That is not science fiction—it is the stated goal of three ...
You eat clean. You exercise. You take the supplements. But what if your cells are still running on a damaged script written decades before you were bo...
Every week, another longevity app tells me my 'biological age.' Usually it's a number pulled from a blood test or a methylation panel. But whose biolo...
Imagine a world where 90-year-olds have the biological age of 40. Clinical trials for senolytic drugs are clearing age-related diseases at rates no on...
Your company will pivot. Maybe not this quarter, but soon. And when it does, most frameworks — the ones you spent months building — will shatter. They...
Imagine you are builded a longevity setup — a stack of intervening, biomarkers, and protocols — but the clock is ticking. Your investors want a go/no-...
Planned obsolescence is not an accident—it's a concept choice incentivized by the faulty metrics. For decades, engineers have measured reliability usi...
You have a compound that extends mouse lifespan by 15%. Your cells look younger under the microscope. Investors are excited. But when you scale to hum...